Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease

So far, there is no effective disease-modifying therapies for Alzheimer’s Disease (AD) in clinical practice. In this context, glycine-L-proline-L-glutamate (GPE) and its analogs may open the way for developing a novel molecule for treating neurodegenerative disorders, including AD. In turn, this stu...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Biomolecules
Main Authors: Turkez, Hasan, Cacciatore, Ivana, Marinelli, Lisa, Fornasari, Erika, Aslan, Mehmet Enes, Cadirci, Kenan, Kahraman, Cigdem Yuce, Caglar, Ozge, Tatar, Abdulgani, Di Biase, Giuseppe, Hacimuftuoglu, Ahmet, Di Stefano, Antonio, Mardinoglu, Adil
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835747/
https://ncbi.nlm.nih.gov/pubmed/33478054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom11010126
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker